Regulations.gov document
Guidance for Industry: Enforcement Policy Regarding Investigational New Drug Requirements…
Notice · FDA-2013-D-0811 · posted Feb 26, 2014
Key facts
| Document ID | FDA-2013-D-0811-0003 |
|---|---|
| Title | Guidance for Industry: Enforcement Policy Regarding Investigational New Drug Requirements for Use of Fecal Microbiota for Transplantation To Treat Clostridium difficile Infection Not Responsive to Standard Therapies; Availability |
| Document type | Notice |
| Subtype | Notice of Availability |
| Agency | FDA |
| Docket | FDA-2013-D-0811 |
| Posted | Feb 26, 2014 |
| Federal Register citation | 79 FR 10814 |
| FR document number | 2014-04095 |
| Comment period opens | Feb 26, 2014 |
| Comments due | Mar 29, 2014 |
| Effective date | Feb 26, 2014 |
At a glance
- 1–9 Pages
- No Open for comment
- 100–999 Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: